Status:
UNKNOWN
Prognostic of Dysfunctional Breathing in Long Covid: a Follow up Study
Lead Sponsor:
Hôpital du Valais
Conditions:
COVID-19
Dysfunctional Breathing
Eligibility:
All Genders
14+ years
Brief Summary
Dysfunctional breathing might participate to dyspnoea in long COVID-19. This study investigate the prognosis of patients diagnosed with dysfunctional breathing after SARS-CoV-2 infection in our center...
Detailed Description
Dysfunctional breathing (DB) with or without hyperventilation syndrome (HVS) as diagnosed using cardiopulmonary exercise test (CPET) was recently demonstrated as an important physiopathological mechan...
Eligibility Criteria
Inclusion
- patients 14 years or more
- diagnosis of DB after SARS-CoV-2 at our long covid clinic using a combined approach of symptoms and CPET analysis in the hospitals of Sion, Martigny or Rennaz
- Inclusion between November 2020 and until the end of October 2021
Exclusion
- Refusal to participate
- comorbidities preventing the CPET or PFT to be carried out
Key Trial Info
Start Date :
November 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05217875
Start Date
November 1 2021
End Date
August 1 2022
Last Update
February 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalier du valais romand
Martigny-Ville, Switzerland